AGL 38.00 No Change ▼ 0.00 (0%)
AIRLINK 136.21 Decreased By ▼ -0.24 (-0.18%)
BOP 5.38 Decreased By ▼ -0.06 (-1.1%)
CNERGY 3.72 Decreased By ▼ -0.08 (-2.11%)
DCL 7.41 Decreased By ▼ -0.09 (-1.2%)
DFML 45.40 Decreased By ▼ -0.01 (-0.02%)
DGKC 78.25 Decreased By ▼ -0.27 (-0.34%)
FCCL 28.58 Decreased By ▼ -0.31 (-1.07%)
FFBL 56.10 Decreased By ▼ -0.90 (-1.58%)
FFL 8.93 Decreased By ▼ -0.34 (-3.67%)
HUBC 101.70 Increased By ▲ 4.90 (5.06%)
HUMNL 13.15 Decreased By ▼ -0.25 (-1.87%)
KEL 3.75 Decreased By ▼ -0.02 (-0.53%)
KOSM 7.30 Increased By ▲ 0.02 (0.27%)
MLCF 37.05 Decreased By ▼ -0.75 (-1.98%)
NBP 66.60 Decreased By ▼ -0.90 (-1.33%)
OGDC 164.80 Decreased By ▼ -2.72 (-1.62%)
PAEL 24.80 Decreased By ▼ -0.30 (-1.2%)
PIBTL 6.62 Decreased By ▼ -0.08 (-1.19%)
PPL 128.00 Decreased By ▼ -3.50 (-2.66%)
PRL 23.86 Decreased By ▼ -2.54 (-9.62%)
PTC 14.80 Decreased By ▼ -0.30 (-1.99%)
SEARL 60.87 Decreased By ▼ -1.38 (-2.22%)
TELE 6.90 Decreased By ▼ -0.10 (-1.43%)
TOMCL 35.80 Decreased By ▼ -0.43 (-1.19%)
TPLP 7.65 Decreased By ▼ -0.23 (-2.92%)
TREET 14.05 Increased By ▲ 0.05 (0.36%)
TRG 44.59 Increased By ▲ 0.04 (0.09%)
UNITY 25.84 Decreased By ▼ -0.01 (-0.04%)
WTL 1.20 Decreased By ▼ -0.02 (-1.64%)
BR100 9,089 Decreased By -54.7 (-0.6%)
BR30 27,134 Decreased By -191.8 (-0.7%)
KSE100 85,250 Decreased By -335.3 (-0.39%)
KSE30 26,803 Decreased By -181 (-0.67%)

The fate and legacy of global cycling icon Lance Armstrong could take a decisive turn when the International Cycling Union (UCI) meets to decide on the American's spectacular fall from grace here Monday. For some observers, the credibility of the sport's governing body, the UCI, may also be on the line.
Armstrong's reputation as the cancer survivor who claimed a record seven consecutive Tour de France victories is now in tatters after he was handed a life ban by the United States Anti-Doping Agency (USADA). The USADA have also stripped Armstrong of his wins after finding him guilty of being at the centre of the biggest doping programme in sporting history.

Copyright Agence France-Presse, 2012

Comments

Comments are closed.